Swedish biotech outfit Melt&Marble has raised €7.3m ($8.5m) in Series A venture capital financing to scale production and bring its first ingredients to market.
The Gothenburg company uses precision fermentation to produce high-performance alternatives to conventional oils and fats for use in personal care and food applications.
Melt&Marble’s product pipeline spans fats designed to unlock functionality across multiple categories, including skin care, and hair care.
The new funding will take Melt&Marble from demo to market-ready, with its first ingredients set for commercial launch in personal care applications in 2026.
Production volumes will be delivered through an existing commercial manufacturing partner, ensuring capex-light scalability.
“This investment marks a major milestone for Melt&Marble as we transition from R&D to commercialisation,” said CEO Anastasia Krivoruchko.
“With key scalability milestones already achieved and strategic partners onboard, we’re entering the market with the capabilities and confidence to deliver real impact,” she added.
“Our vision has always been to deliver more sustainable, high-performance ingredients, and this round brings us significantly closer to that goal.”
The €7m Series A round was led by Swedish deeptech investor Industrifonden, with participation from the European Commission’s European Innovation Council (EIC) Fund and strategic partners Beiersdorf and Valio, key players in the personal care and food sectors, respectively.
Additional backing came from Chalmers Ventures and Catalyze Capital.
Tobias Elmquist, Senior Investment Director at Industrifonden, said: “Melt&Marble has achieved an impressive level of technical and commercial readiness for a company at this stage.
“Their ability to engineer functional fats through precision fermentation addresses a clear and growing demand across industries.”
